Large-scale testing (Phase 3)Study completedNCT02632409
What this trial is testing
An Investigational Immuno-therapy Study of Nivolumab, Compared to Placebo, in Patients With Bladder or Upper Urinary Tract Cancer, Following Surgery to Remove the Cancer
Who this might be right for
Various Advanced Cancer
Bristol-Myers Squibb 709